Sponsor Information
JANSSEN-CILAG PTY LTD
Active Ingredients
Ustekinumab
462457
SETRELVO ustekinumab 45 mg/ 0.5 mL solution for injection pre-filled pen (One-Press patient-controlled injector)
Janssen-Cilag Pty Ltd
October 18, 2024
Medicine
Medicine
Registered
JANSSEN-CILAG PTY LTD
Ustekinumab
Empowering clinical research with data-driven insights and AI-powered tools.
© 2025 MedPath, Inc. All rights reserved.